Regencell Investors Sue Over Undisclosed DOJ Probe, Stock Plunges 18.56%
Class action lawsuit filed against Regencell Bioscience for alleged false statements and failure to disclose DOJ investigation into trading practices.
RGCsecurities fraudclass action lawsuit
